3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
2
Unknown
1
Terminated
1
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Melanoma
30
Neoplasm Metastasis
17
Skin Neoplasms
9
Leukemia, Myeloid, Acute
8
Neoplasms
7
Kidney Neoplasms
7
Ovarian Neoplasms
6
Carcinoma, Renal Cell
6
Carcinoma, Non-Small-Cell Lung
5
Stomach Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Pancreatic Neoplasms
4
Neuroblastoma
4
Lymphoma, Non-Hodgkin
4
Leukemia
4
Breast Neoplasms
4
Lymphoma
3
Lung Neoplasms
3
Congenital Abnormalities
3
Colorectal Neoplasms
3
Uterine Cervical Neoplasms
2
Unspecified Adult Solid Tumor, Protocol Specific
2
Triple Negative Breast Neoplasms
2
Sezary Syndrome
2
Rectal Neoplasms
2
Myelodysplastic Syndromes
2
Mycosis Fungoides
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large-Cell, Immunoblastic
2
Interventions
Doxorubicin
13
Gemcitabine
10
Cyclophosphamide
10
pazopanib
8
Filgrastim
8
Radiotherapy
7
Ifosfamide
7
Cisplatin
7
Irinotecan
6
Docetaxel
6
Radiation
5
Granulocyte Colony-Stimulating Factor
5
Etoposide
5
Trabectedin
4
Magnetic Resonance Spectroscopy
4
Celecoxib
4
Busulfan
4
Bevacizumab
4
Albumin-Bound Paclitaxel
4
temsirolimus
3
sargramostim
3
pembrolizumab
3
X-Rays
3
Sirolimus
3
Radiotherapy, Intensity-Modulated
3
Paclitaxel
3
Neoadjuvant Therapy
3
Leucovorin
3
Dexrazoxane
3
Cryosurgery
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Sarcoma
×
aldesleukin
×
Clear all
NCT03240861
2023-11-01
NYESO SCT
Jonsson Comprehensive Cancer Center
Phase 1
Terminated
5 enrolled